Unmodified drug used as a material to construct nanoparticles: Delivery of cisplatin for enhanced anti-cancer therapy

Journal of Controlled Release

Volumn 174, Issue 1, 2014, Pages 137-142

  Guo, Shutao ^a   Miao, Lei ^a   Wang, Yuhua ^a   Huang, Leaf ^a  

^a University of North Carolina   (United States)

Author keywords

Cisplatin; Drug delivery; Microemulsion; Nanoparticle; Nanoprecipitate

Indexed keywords

ANTI-CANCER THERAPIES; ANTI-TUMOR ACTIVITIES; CIS-PLATIN; HIGH DRUG LOADINGS; NANOPARTICLE (NPS); NANOPARTICLE SYNTHESIS; NANOPRECIPITATE; REVERSE MICROEMULSIONS;

COATINGS; DISPERSIONS; DRUG DELIVERY; LIPID BILAYERS; MICROEMULSIONS; NANOPARTICLES; PHOTOELECTRONS; PLATINUM COMPOUNDS; SOLUBILITY; X RAY PHOTOELECTRON SPECTROSCOPY;

SYNTHESIS (CHEMICAL);

CISPLATIN; DOPA; NANOPARTICLE; ORGANIC SOLVENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PURIFICATION; DRUG STABILITY; FEMALE; IN VITRO STUDY; MICROEMULSION; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; X RAY PHOTOELECTRON SPECTROSCOPY;

CISPLATIN; DRUG DELIVERY; MICROEMULSION; NANOPARTICLE; NANOPRECIPITATE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; DRUG CARRIERS; FEMALE; HUMANS; LIPIDS; MICE; MICE, NUDE; NANOPARTICLES; NEOPLASMS; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84890002586     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.11.019     Document Type: Article

References (34)

1. X. Yao, K. Panichpisal, N. Kurtzman, and K. Nugent Cisplatin nephrotoxicity: a review Am. J. Med. Sci. 334 2007 115 124 (Pubitemid 47262919)
2. N. Pabla, and Z. Dong Cisplatin nephrotoxicity: mechanisms and renoprotective strategies Kidney Int. 73 2008 994 1007 (Pubitemid 351543900)
3. R. Plummer, R.H. Wilson, H. Calvert, A.V. Boddy, M. Griffin, J. Sludden, M.J. Tilby, M. Eatock, D.G. Pearson, C.J. Ottley, Y. Matsumura, K. Kataoka, and T. Nishiya A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours Br. J. Cancer 104 2011 593 598
4. H. Cabral, Y. Matsumoto, K. Mizuno, Q. Chen, M. Murakami, M. Kimura, Y. Terada, M.R. Kano, K. Miyazono, M. Uesaka, N. Nishiyama, and K. Kataoka Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size Nat. Nanotechnol. 6 2011 815 823
5. M. Baba, Y. Matsumoto, A. Kashio, H. Cabral, N. Nishiyama, K. Kataoka, and T. Yamasoba Micellization of cisplatin (NC-6004) reduces its ototoxicity in guinea pigs J. Control. Release 157 2012 112 117
6. P. Sengupta, S. Basu, S. Soni, A. Pandey, B. Roy, M.S. Oh, K.T. Chin, A.S. Paraskar, S. Sarangi, Y. Connor, V.S. Sabbisetti, J. Kopparam, A. Kulkarni, K. Muto, C. Amarasiriwardena, I. Jayawardene, N. Lupoli, D.M. Dinulescu, J.V. Bonventre, R.A. Mashelkar, and S. Sengupta Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity Proc. Natl. Acad. Sci. U. S. A. 109 2012 11294 11299
7. K.J. Harrington, G. Rowlinson-Busza, K.N. Syrigos, R.G. Vile, P.S. Uster, A.M. Peters, and J.S. Stewart Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft model Clin. Cancer Res. 6 2000 4939 4949 (Pubitemid 32110440)
8. N. Zisman, N. Dos Santos, S. Johnstone, A. Tsang, D. Bermudes, L. Mayer, and P. Tardi Optimizing liposomal cisplatin efficacy through membrane composition manipulations Chemother. Res. Pract. 2011 2011
9. W. Zamboni, A. Gervais, M. Egorin, J.M. Schellens, E. Zuhowski, D. Pluim, E. Joseph, D. Hamburger, P. Working, G. Colbern, M. Tonda, D. Potter, and J. Eiseman Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma Cancer Chemother. Pharmacol. 53 2004 329 336 (Pubitemid 38392358)
10. D.M. Vail, I.D. Kurzman, P.C. Glawe, M.G. O'Brien, R. Chun, L.D. Garrett, J.E. Obradovich, R.M. Fred III, C. Khanna, G.T. Colbern, and P.K. Working STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trial Cancer Chemother. Pharmacol. 50 2002 131 136 (Pubitemid 34969509)
11. N. Seetharamu, E. Kim, H. Hochster, F. Martin, and F. Muggia Phase II study of liposomal cisplatin (SPI-77) in platinum-sensitive recurrences of ovarian cancer Anticancer Res. 30 2010 541 545
12. A. Schroeder, R. Honen, K. Turjeman, A. Gabizon, J. Kost, and Y. Barenholz Ultrasound triggered release of cisplatin from liposomes in murine tumors J. Control. Release 137 2009 63 68
13. S. Dhar, N. Kolishetti, S.J. Lippard, and O.C. Farokhzad Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo Proc. Natl. Acad. Sci. U. S. A. 108 2011 1850 1855
14. K. Avgoustakis, A. Beletsi, Z. Panagi, P. Klepetsanis, A.G. Karydas, and D.S. Ithakissios PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties J. Control. Release 79 2002 123 135 (Pubitemid 34164166)
15. N. Kolishetti, S. Dhar, P.M. Valencia, L.Q. Lin, R. Karnik, S.J. Lippard, R. Langer, and O.C. Farokhzad Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy Proc. Natl. Acad. Sci. U. S. A. 107 2010 17939 17944
16. S. Dhar, F.X. Gu, R. Langer, O.C. Farokhzad, and S.J. Lippard Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles Proc. Natl. Acad. Sci. U. S. A. 105 2008 17356 17361
17. T. Boulikas Clinical overview on Lipoplatin: a successful liposomal formulation of cisplatin Expert Opin. Investig. Drugs 18 2009 1197 1218
18. T. Boulikas, Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes, in, United States Patent 6,511,676 (2003).
19. R.A. Alderden, M.D. Hall, and T.W. Hambley The discovery and development of cisplatin J. Chem. Educ. 83 2006 728 734
20. S. Aryal, C.-M.J. Hu, and L. Zhang Polymer-cisplatin conjugate nanoparticles for acid-responsive drug delivery ACS Nano 4 2009 251 258
21. N. Graf, D.R. Bielenberg, N. Kolishetti, C. Muus, J. Banyard, O.C. Farokhzad, and S.J. Lippard αvβ3 Integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt (IV) prodrug ACS Nano 6 2012 4530 4539
22. Y. Zhang, W.Y. Kim, and L. Huang Systemic delivery of gemcitabine triphosphate via LCP nanoparticles for NSCLC and pancreatic cancer therapy Biomaterials 34 2013 3447 3458
23. J. Li, Y. Yang, and L. Huang Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor J. Control. Release 158 2012 108 114
24. Y. Hu, M.T. Haynes, Y. Wang, F. Liu, and L. Huang A highly efficient synthetic vector: nonhydrodynamic delivery of DNA to hepatocyte nuclei in vivo ACS Nano 7 2013 5376 5384
25. R. Banerjee, P. Tyagi, S. Li, and L. Huang Anisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells Int. J. Cancer 112 2004 693 700 (Pubitemid 39425952)
26. K.N. Burger, R.W. Staffhorst, H.C. de Vijlder, M.J. Velinova, P.H. Bomans, P.M. Frederik, and B. de Kruijff Nanocapsules: lipid-coated aggregates of cisplatin with high cytotoxicity Nat. Med. 8 2002 81 84 (Pubitemid 34101733)
27. S. Khiati, D. Luvino, K. Oumzil, B. Chauffert, M. Camplo, and P. Barthélémy Nucleoside-lipid-based nanoparticles for cisplatin delivery ACS Nano 5 2011 8649 8655
28. M.J. Velinova, R.W. Staffhorst, W.J. Mulder, A.S. Dries, B.A. Jansen, B. de Kruijff, and A.I. de Kroon Preparation and stability of lipid-coated nanocapsules of cisplatin: anionic phospholipid specificity Biochim. Biophys. Acta Biomembr. 1663 2004 135 142 (Pubitemid 38625588)
29. C.-A.J. Lin, R.A. Sperling, J.K. Li, T.-Y. Yang, P.-Y. Li, M. Zanella, W.H. Chang, and W.J. Parak Design of an amphiphilic polymer for nanoparticle coating and functionalization Small 4 2008 334 341 (Pubitemid 351421263)
30. T. Chen, I. Öçsoy, Q. Yuan, R. Wang, M. You, Z. Zhao, E. Song, X. Zhang, and W. Tan One-step facile surface engineering of hydrophobic nanocrystals with designer molecular recognition J. Am. Chem. Soc. 134 2012 13164 13167
31. A.L. Klibanov, K. Maruyama, V.P. Torchilin, and L. Huang Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes FEBS Lett. 268 1990 235 237 (Pubitemid 20233874)
32. O. Nakagawa, X. Ming, L. Huang, and R.L. Juliano Targeted intracellular delivery of antisense oligonucleotides via conjugation with small-molecule ligands J. Am. Chem. Soc. 132 2010 8848 8849
33. Y. Xu, and F.C. Szoka Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection †,‡ Biochemistry 35 1996 5616 5623 (Pubitemid 26143656)
34. S. Guo, Y. Wang, L. Miao, Z. Xu, C.M. Lin, Y. Zhang, and L. Huang Lipid-coated cisplatin nanoparticles induce neighboring effect and exhibit enhanced anticancer efficacy ACS Nano 7 2013 9896 9904